← Eichor
Study identifier: NCT07044323 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Efficacy and Mechanisms of Virtual Reality Treatment of Phantom Leg Pain.Home-Based Treatment

Condition: Phantom Pain Following Amputation of Lower Limb · Amputation  ·  Sponsor: Albert Einstein Healthcare Network

PhaseNA
Planned participants44
Who can joinAll sexes, 18 Years to 100 Years
Healthy volunteersNo

About this study

After amputation of an arm or leg, up to 90% of subjects experience a "phantom limb", a phenomenon characterized by persistent feelings of the missing limb. Many subjects with a phantom limb experience intense pain in the missing extremity that is often poorly responsive to medications or other interventions. The study will explore the feasibility and efficacy of a home-based, active VR treatment for phantom limb pain (PLP).

This description comes directly from the study's public registry record.

Talk to the study team

Laurel Buxbaum  ·  215-663-6321  ·  Laurel.Buxbaum@jefferson.edu

Always discuss trial participation with your own doctor first.

Locations (3)

Jefferson Moss Rehabilitation Research InstitutePhiladelphia, Pennsylvania, United StatesRecruiting
University of PennsylvaniaPhiladelphia, Pennsylvania, United StatesRecruiting
University of WashingtonSeattle, Washington, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07044323